Education, Science, Technology, Innovation and Life
Open Access
Sign In
  1. Home
  2. Journals
  3. MEDS Clinical Medicine
  4. Vol 7, Issue 1, 2026

Discussion on Treatment Modalities for Cesarean Scar Defect

Download as PDF

DOI: 10.23977/medsc.2026.070118 | Downloads: 2 | Views: 144

Author(s)

Jingjing Li 1, Hui Zhang 1, Ye Liang 1

Affiliation(s)

1 Department of Obstetrics and Gynecology, Affiliated Hospital of Hebei University, Baoding, Hebei, 071000, China

Corresponding Author

Hui Zhang

ABSTRACT

The incidence of post-cesarean scar defect(PCSD) after cesarean section is increasing annually,which is significantly impacting patients' quality of life. This study analyzed clinical data from 156 patients with PCSD, divided into three groups based on treatment modality: Group A (hysteroscopic surgery, n=47), Group B (laparoscopic surgery, n=57), and Group C (LNG-IUS, n=52). The primary outcomes compared were post-treatment duration of postmenstrual spotting, treatment costs, and intraoperative blood loss. The results showed total effective rates of 68.08%, 78.95%, and 94.23% for Groups A, B, and C, respectively. Group A demonstrated advantages over Group B, including reduced blood loss, lower hospitalization costs, and shorter operative time. In conclusion, the choice of treatment modality should be individualized based on factors such as fertility requirements, residual myometrial thickness at the scar site, and diverticulum dimensions.

KEYWORDS

Post-Cesarean Scar Defect, Hysteroscopy, LNG-IUS

CITE THIS PAPER

Jingjing Li, Hui Zhang, Ye Liang. Discussion on Treatment Modalities for Cesarean Scar Defect. MEDS Clinical Medicine (2026). Vol. 7, No.1, 183-190. DOI: http://dx.doi.org/10.23977/medsc.2026.070118.

REFERENCES

[1] Tower A.M., Frishman G.N. Cesarean scar defects: an underrecognized cause of abnormal uterine bleeding and other gynecologic complications. J Minim Invasive Gynecol. 2013. 20(5): 562-572.
[2] Pan H., Zeng M., Xu T. The prevalence and risk predictors of cesarean scar defect at 6 weeks postpartum in Shanghai, China: A prospective cohort study. Acta Obstet Gynecol Scand. 2019. 98(4): 413-422.
[3] Li H.T., Luo S.L.,Leo T. Geographic variations and temporal trends in cesarean delivery rates in China,2008-2014. JAMA.2017. 317(1): 69-76.
[4] Feng X.L., Xu L., Guo Y. Socioeconomic inequalities in hospital births in China between 1988 and 2008. Bull World Health Organ. 2011. 89(6): 432-441.
[5] Family Planning Branch of Chinese Medical Association. Expert guideline for diagnosis and treatment of PCSD. Chinese Journal of Obstetrics and Gynecology. 2019. 54(3): 145-148.
[6] Glenn T.L., Han E. Cesarean scar defect: far from understood. Fertil Steril. 2021. 116(2): 369-370.
[7] Tulandi T., Cohen A. Emerging Manifestations of Cesarean Scar Defect in Reproductive-aged Women. J Minim Invasive Gynecol. 2016. 23(6): 893-902.
[8] Vaate A., Brlmann H., Voet L. Ultrasound evaluation of the Cesarean scar: relation between a niche and postmenstrual spotting. Ultrasound Obstetrics and Gynecology. 2011. 37(1).
[9] Naimi A., Wolnicki B., Mouzakiti N. Anatomy of the sonographic post-cesarean uterus. Arch Gynecol Obstet. 2021. 304(6): 1485-1491.
[10] Zou J.M., Luo S.Y., Ye L.J. Clinical observation f trimming lower uterine segment scar combined with Gongkangning for preventing PCSD in second cesarean section in scarred uterus. Medicine Theory and Practice. 2022. 35(23): 4053-4055.
[11] Morris, Hugh. Surgical Pathology of the Lower Uterine Segment Caesarean Section Scar. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY. 1995. 14(1): 16-20.
[12] Xin L., Lin X., Pan Y. A collagen scaffold loaded with human umbilical cord-derived mesenchymal stem cells facilitates endometrial regeneration and restores fertility. Acta Biomater. 2019. 92: 160-171.
[13] Jordans I., Vissers J., Huang Y. Increased amplitude of subendometrial contractions identified by ultrasound speckle tracking in women with a caesarean scar defect. Reprod Biomed Online. 2023. 46(3): 577-587.
[14] Mutairi B., Alrumaih I. Hysteroscopy in the Treatment of Myometrial Scar Defect (Diverticulum) Following Cesarean Section Delivery: A Systematic Review and Meta-Analysis. Cureus. 2020. 12(11).
[15] Iannone P. Isthmocele:from risk factors to management. Rev Bras Ginecol Obstet. 2019. 41(1): 44-52.
[16] Bujold E., Jastrow N., Simoneau J. Prediction of complete uterine rupture by sonographic evaluation of the lower uterine segment. Am J Obstet Gynecol. 2009. 201(3): 320.e1-6.
[17] Fan R., Deng S. Analysis of the Efficacy of Hysteroscopic Treatment for Cesarean Section Scar Defect. Journal of Reproductive Medicine.2019. 28(8): 866-871.
[18] Tsuji S., Takahashi A., Higuchi A. Pregnancy outcomes after hysteroscopic surgery in women with cesarean scar syndrome. PLoS One. 2020. 15(12): e0243421.
[19] Niu G., Luo L., He K. Transvaginal resection of uterine scar divericulum after cesarean section: a clinical analysis of 34 cases . Chinese Journal of Practical Obstetrics and Gynecology. 2012. 28(03): 209-211.
[20] You J.J., Huang Y.J., Zhao W.X.l. Analysis of the Efficacy of Hysteroscopic Surgery versus Combined Hysteroscopic and Laparoscopic Surgery in the Treatment of Cesarean Scar Diverticulum. Journal of Zunyi Medical University.2022. (02):352-358.
[21] Zhang N.N., Wang G.W., Yang Q. Analysis of Clinical Treatment for 52 Cases of Cesarean Scar Diverticulum. Journal of Reproductive Medicine. 2017. 26(04): 331-335.
[22] Yu H., Huang Y.J., Wang Y.J. Analysis of the Preventive Effect of Previous Uterine Scar Trimming on Cesarean Scar Diverticulum in Second Cesarean Section. Chinese Journal of Maternal and Child Health Care. 2020. 35(11): 2115-2117.
[23] Liu L.M., Li Z.M. Analysis of the Efficacy of Continuous Folded Suturing of the Lower Uterine Segment in Reinforcing the Absence of Myometrium at the Uterine Scar. Journal of Modern Medicine and Health. 2023. 7(10): 66-68.
[24] Wu X.X., Zhu R., Wei Z.L. Analysis of the Efficacy of Hysteroscopy Combined with Transvaginal Folded Suturing in the Treatment of Cesarean Scar Diverticulum. Current Progress in Obstetric and Gynecology. 2023. 32(02): 113-117.
[25] Xiao J.L, Zhang W.Y., Zhang M. Treatment Modalities and Outcomes of Cesarean Scar Diverticulum.Journal of Wuhan Medical University.2023.44(3):324-334.
[26] Hu Z.H., Guo H.J. Efficacy of Mirena in the Treatment of Abnormal Uterine Bleeding Induced by Cesarean Scar Diverticulum. Journal of Practical Obstetrics and Gynecology. 2022. 9(31): 30-33.
[27] Zhu Q., He X., Jiang L. Effectiveness of hysteroscopic resection of a uterine caesarean niche can be predicted: a prospective cohort study. Sci Rep. 2020. 10(1): 17424.
[28] Cheng X.Y., Cheng L., Li W.J. The effect of surgery on subsequent pregnancy outcomes among patients with cesarean scar diverticulum. Int J Gynaecol Obstet. 2018. 141(2): 212-216.
[29] Zhang Y. A Comparative Study of Transvaginal Repair and Laparoscopic Repair in the Management of Patients With Previous Cesarean Scar Defect. Journal of Minimally Invasive Gynecology. 2016: 535-541.
[30] Osser O.V., Valentin L. Risk factors for incomplete healing of the uterine incision after caesarean section: General obstetrics. BJOG An International Journal of Obstetrics & Gynaecology. 2010. 117(9): 1119-1126.
[31] Vikhareva O., Rickle G.S., Lavesson T,et al. Hysterotomy level at Cesarean section and occurrence of large scar defects: a randomized single-blind trial. Ultrasound Obstet Gynecol. 2019. 53(4): 438-442.
[32] Huang D., Chen S., Cai Y. Adjunctive azithromycin prophylaxis protects women from uterine cesarean scar defect: A randomized controlled trial. Acta Obstet Gynecol Scand. 2022. 101(8): 889-900.

Subscription
E-Mail Alert
Most popular papers
Call for Special Issue
Publication Ethics & OA Statement
Plagiarism Policy
Contact Us
Downloads: 11295
Visits: 905264

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.